Arnold Lee D 4
4 · PARDES BIOSCIENCES, INC. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Arnold Lee D
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+100,000→ 100,000 totalExercise: $11.32Exp: 2032-01-31→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option shall vest in substantially equal monthly installments over four years from February 1, 2022, subject to a continued service relationship. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2021 Stock Option and Incentive Plan with the U.S. Securities and Exchange Commission.